1.Troponin-Positive Non-Obstructive Coronary Arteries and Myocardial Infarction with Non-Obstructive Coronary Arteries: Definition, Etiologies, and Role of CT and MR Imaging
Seung Min YOO ; Sowon JANG ; Jeong A KIM ; Eun Ju CHUN
Korean Journal of Radiology 2020;21(12):1310-1321
In approximately 10% of patients with acute myocardial infarction (MI), angiography does not reveal an obstructive coronary stenosis. This is known as myocardial infarction with non-obstructive coronary arteries (MINOCA), which has complex and multifactorial causes. However, this term can be confusing and open to dual interpretation, because MINOCA is also used to describe patients with acute myocardial injury caused by ischemia-related myocardial necrosis. Therefore, with regards to this specific context of MINOCA, the generic term for MINOCA should be replaced with troponin-positive with non-obstructive coronary arteries (TpNOCA). The causes of TpNOCA can be subcategorized into epicardial coronary (causes of MINOCA), myocardial, and extracardiac disorders. Cardiac magnetic resonance imaging can confirm MI and differentiate various myocardial causes, while cardiac computed tomography is useful to diagnose the extracardiac causes.
2.Troponin-Positive Non-Obstructive Coronary Arteries and Myocardial Infarction with Non-Obstructive Coronary Arteries: Definition, Etiologies, and Role of CT and MR Imaging
Seung Min YOO ; Sowon JANG ; Jeong A KIM ; Eun Ju CHUN
Korean Journal of Radiology 2020;21(12):1310-1321
In approximately 10% of patients with acute myocardial infarction (MI), angiography does not reveal an obstructive coronary stenosis. This is known as myocardial infarction with non-obstructive coronary arteries (MINOCA), which has complex and multifactorial causes. However, this term can be confusing and open to dual interpretation, because MINOCA is also used to describe patients with acute myocardial injury caused by ischemia-related myocardial necrosis. Therefore, with regards to this specific context of MINOCA, the generic term for MINOCA should be replaced with troponin-positive with non-obstructive coronary arteries (TpNOCA). The causes of TpNOCA can be subcategorized into epicardial coronary (causes of MINOCA), myocardial, and extracardiac disorders. Cardiac magnetic resonance imaging can confirm MI and differentiate various myocardial causes, while cardiac computed tomography is useful to diagnose the extracardiac causes.
3.The Effect of Oral Carbohydrate-Rich Solution Administration for Reducing Discomfort and Adverse Reactions in Patients for Coronary Computed Tomographic Angiography
Cardiovascular Imaging Asia 2025;9(1):9-14
Objective:
This study aimed to evaluate the effect of administration of oral carbohydrate-rich solution (ORS) for reducing discomfort and adverse effects of contrast media in patients who should undergo coronary computed tomographic angiography (CCTA).
Materials and Methods:
A total 142 patients scheduled for CCTA were randomly divided into two different groups. Patients assigned to group A (n=71) were instructed to maintain fasting at least 6 hours before CCTA. Patients in group B (n=71) were allowed to freely drink ORS up to three cans until 2 hours before CCTA. Subjective discomfort was assessed in both groups by questionnaires consisting of 5 different items that scored from 0 to 10 for each items 2 hours prior to and 30 minutes after CCTA. Acute side effects to contrast media including emetic complication were evaluated in both groups.
Results:
The ORS was well-tolerated in all patients without causing any unexpected complications. In group B, scores reflecting subjective discomfort were significantly lower than those of group A before (20.8±6.2 vs. 15.1±6.3; p<0.001) and after the CCTA (22.5±6.0 vs. 16.3± 5.0; p<0.001). In addition, emetic symptoms were significantly lower in group B than in group A after the CCTA (p=0.012). Aspiration pneumonia or contrast induced nephropathy were not observed in both groups.
Conclusion
Our study suggests that preparative ORS intake before CCTA is a safe practice to reduce adverse effects on contrast media and improve patients’ discomfort without causing aspiration pneumonia.
4.The Effect of Formula-based Nutritional Treatment on Colitis in a Murine Model
Sooyoung JANG ; Younjuong KIM ; Changjun LEE ; Bomi KWON ; Jihye NOH ; Jai J. JEE ; Sang Sun YOON ; Hong KOH ; Sowon PARK
Journal of Korean Medical Science 2021;36(50):e342-
Background:
Exclusive enteral nutrition (EEN) induces remission in pediatric Crohn's disease (CD). The exact mechanism of EEN therapy in CD is unknown, but alteration of the intestinal microflora after EEN is thought to affect mucosal healing. To determine the link between EEN therapy and therapeutic efficacy in CD, we established a murine model of dextran sulfate sodium (DSS)-induced colitis and applied EEN therapy.
Methods:
Eight-week-old C57BL/6 mice were administered DSS for 4 days to induce colitis, and either normal chow (NC) or EEN was administered for the following 4 days. The mice were grouped according to the feeding pattern after DSS administration: DSS/NC and DSS/ EEN groups. The clinical course was confirmed via daily observation of the weight and stool. Fecal samples were collected and 16sRNA sequencing was used. The mice were sacrificed to confirm colonic histopathology.
Results:
Weight reduction and increase in disease activity were observed as the day progressed for 4 days after DSS administration. There was significant weight recovery and improvement in disease activity in the EEN group compared to that in the NC group. Verrucomicrobia and Proteobacteria abundances tended to increase and Bacteroidetes abundance decreased in the EEN group. In the EEN group, significant changes in the β-diversity of the microbiota were observed. In the analysis of microbiome species, abundances of Akkermansia muciniphila, Clostridium cocleatum, mucin-degrading bacteria, Flintibacter butyricus, and Parabacteroides goldsteinii, which are beneficial microbiota, were significantly increased in the EEN group compared to those in the NC group. More abundant mucins were confirmed in the colonic histopathology of the EEN group. These microbial and histopathological differences suggested that EEN might improve colitis symptoms in a murine colitis model by promoting mucin recycling and subsequently inducing the healing effect of the gut barrier.
Conclusion
EEN showed clinical efficacy in a murine model of colitis. Based on the increase in mucin-degrading bacteria and the pathological increase in mucin production after EEN administration, it can be observed that mucin plays an important role in the therapeutic effect of EEN.